Baricitinib for COVID-19: a suitable treatment?
Ennio Giulio Favalli, Martina Biggioggero, Gabriella Maioli, Roberto Caporali
Topics & Concepts
Janus kinaseMedicineRheumatoid arthritisTofacitinibImmunologyInterferonCoronavirusInnate immune systemViral replicationVirologyImmune systemBioinformaticsDiseaseVirusCoronavirus disease 2019 (COVID-19)BiologyCytokineInfectious disease (medical specialty)Internal medicineSARS-CoV-2 and COVID-19 Researchinterferon and immune responsesViral Infections and Vectors